Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10618963
APP PUB NO 20180009893A1
SERIAL NO

15698800

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present specification discloses a pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the CNS. The pharmaceutical composition is administered by a dosage regimen comprising at least one course of therapy, each course of therapy comprising in sequence a treatment session followed by an interval session of non-treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
YEDA RESEARCH AND DEVELOPMENT CO LTDWEIZMANN INSTITUTE OF SCIENCE P O BOX 95 REHOVOT 7610002 ISRAEL

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baruch, Kuti Rehovot, IL 27 327
Eisenbach-Schwartz, Michal Rehovot, IL 71 680
Rosenzweig, Neta Rehovot, IL 25 327

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 14, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 14, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00